메뉴 건너뛰기




Volumn 378, Issue 9806, 2011, Pages 1858-1867

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): An open-label randomised phase 3 trial

(22)  Récher, Christian a   Coiffier, Bertrand b   Haioun, Corinne c   Molina, Thierry Jo d   Fermé, Christophe e   Casasnovas, Olivier f   Thiéblemont, Catherine g   Bosly, André h   Laurent, Guy a   Morschhauser, Franck i   Ghesquires, Hervé j   Jardin, Fabrice k   Bologna, Serge l   Fruchart, Christophe m   Corront, Bernadette n   Gabarre, Jean o   Bonnet, Christophe p   Janvier, Maud q   Canioni, Danielle d   Jais, Jean Philippe d   more..


Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINATE CALCIUM; IFOSFAMIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE; VINDESINE;

EID: 82255186682     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61040-4     Document Type: Article
Times cited : (305)

References (29)
  • 1
    • 30144443996 scopus 로고    scopus 로고
    • Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001
    • DOI 10.1182/blood-2005-06-2508
    • LM Morton, SS Wang, SS Devesa, P Hartge, DD Weisenburger, MS Linet Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood 107 2006 265 276 (Pubitemid 43053551)
    • (2006) Blood , vol.107 , Issue.1 , pp. 265-276
    • Morton, L.M.1    Wang, S.S.2    Devesa, S.S.3    Hartge, P.4    Weisenburger, D.D.5    Linet, M.S.6
  • 3
    • 77957200763 scopus 로고    scopus 로고
    • Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the Groupe d'Etudes des Lymphomes de l'Adulte
    • B Coiffier, C Thieblemont, E Van Den Neste et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte Blood 116 2010 2040 2045
    • (2010) Blood , vol.116 , pp. 2040-2045
    • Coiffier, B.1    Thieblemont, C.2    Van Den Neste, E.3
  • 5
    • 33646004738 scopus 로고    scopus 로고
    • CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: A randomised controlled trial by the MabThera International Trial (MInT) Group
    • M Pfreundschuh, L Trumper, A Osterborg et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Lancet Oncol 7 2006 379 391
    • (2006) Lancet Oncol , vol.7 , pp. 379-391
    • Pfreundschuh, M.1    Trumper, L.2    Osterborg, A.3
  • 6
    • 38549147027 scopus 로고    scopus 로고
    • Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: A randomised controlled trial (RICOVER-60)
    • M Pfreundschuh, J Schubert, M Ziepert et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Lancet Oncol 9 2008 105 116
    • (2008) Lancet Oncol , vol.9 , pp. 105-116
    • Pfreundschuh, M.1    Schubert, J.2    Ziepert, M.3
  • 7
    • 77957965500 scopus 로고    scopus 로고
    • Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era
    • C Gisselbrecht, B Glass, N Mounier et al. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era J Clin Oncol 28 2010 4184 4190
    • (2010) J Clin Oncol , vol.28 , pp. 4184-4190
    • Gisselbrecht, C.1    Glass, B.2    Mounier, N.3
  • 10
    • 0027444652 scopus 로고
    • A predictive model for aggressive non-Hodgkin's lymphoma
    • The International Non-Hodgkin's Lymphoma Prognostic Factors Project
    • The International Non-Hodgkin's Lymphoma Prognostic Factors Project A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 1993 987 994
    • (1993) N Engl J Med , vol.329 , pp. 987-994
  • 14
    • 0042449063 scopus 로고    scopus 로고
    • Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group
    • BD Cheson, SJ Horning, B Coiffier et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group J Clin Oncol 17 1999 1244 1250
    • (1999) J Clin Oncol , vol.17 , pp. 1244-1250
    • Cheson, B.D.1    Horning, S.J.2    Coiffier, B.3
  • 15
    • 33646783722 scopus 로고    scopus 로고
    • National Cancer Institute (accessed Oct 11, 2011)
    • National Cancer Institute Common terminology criteria for adverse events v3.0 http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ ctcaev3.pdf (accessed Oct 11, 2011).
    • Common Terminology Criteria for Adverse Events v3.0
  • 17
    • 70349128174 scopus 로고    scopus 로고
    • Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: A phase II multicenter study
    • U Vitolo, A Chiappella, E Angelucci et al. Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study Haematologica 94 2009 1250 1258
    • (2009) Haematologica , vol.94 , pp. 1250-1258
    • Vitolo, U.1    Chiappella, A.2    Angelucci, E.3
  • 18
    • 77958453257 scopus 로고    scopus 로고
    • High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma
    • B Glass, M Ziepert, M Reiser et al. High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma Ann Oncol 21 2010 2255 2261
    • (2010) Ann Oncol , vol.21 , pp. 2255-2261
    • Glass, B.1    Ziepert, M.2    Reiser, M.3
  • 19
    • 45749152667 scopus 로고    scopus 로고
    • Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers
    • WH Wilson, K Dunleavy, S Pittaluga et al. Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers J Clin Oncol 26 2008 2717 2724
    • (2008) J Clin Oncol , vol.26 , pp. 2717-2724
    • Wilson, W.H.1    Dunleavy, K.2    Pittaluga, S.3
  • 20
    • 0022571464 scopus 로고
    • Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)
    • B Coiffier, PA Bryon, F Berger et al. Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80) J Clin Oncol 4 1986 147 153 (Pubitemid 16161028)
    • (1986) Journal of Clinical Oncology , vol.4 , Issue.2 , pp. 147-153
    • Coiffier, B.1    Bryon, P.A.2    Berger, F.3
  • 21
    • 0024379544 scopus 로고
    • LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma
    • B Coiffier, C Gisselbrecht, R Herbrecht, H Tilly, A Bosly, N Brousse LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma J Clin Oncol 7 1989 1018 1026 (Pubitemid 19196524)
    • (1989) Journal of Clinical Oncology , vol.7 , Issue.8 , pp. 1018-1026
    • Coiffier, B.1    Gisselbrecht, C.2    Herbrecht, R.3    Tilly, H.4    Bosly, A.5    Brousse, N.6
  • 23
    • 79960116662 scopus 로고    scopus 로고
    • SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
    • RO Casasnovas, M Meignan, A Berriolo-Riedinger et al. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma Blood 118 2011 37 43
    • (2011) Blood , vol.118 , pp. 37-43
    • Casasnovas, R.O.1    Meignan, M.2    Berriolo-Riedinger, A.3
  • 24
    • 77957331593 scopus 로고    scopus 로고
    • Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma
    • JS Abramson, M Hellmann, JA Barnes et al. Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma Cancer 116 2010 4283 4290
    • (2010) Cancer , vol.116 , pp. 4283-4290
    • Abramson, J.S.1    Hellmann, M.2    Barnes, J.A.3
  • 27
    • 77958501473 scopus 로고    scopus 로고
    • DNA damage-mediated induction of a chemoresistant niche
    • LA Gilbert, MT Hemann DNA damage-mediated induction of a chemoresistant niche Cell 143 2010 355 366
    • (2010) Cell , vol.143 , pp. 355-366
    • Gilbert, L.A.1    Hemann, M.T.2
  • 28
    • 77950332103 scopus 로고    scopus 로고
    • Rituximab: Mechanism of action
    • GJ Weiner Rituximab: mechanism of action Semin Hematol 47 2010 115 123
    • (2010) Semin Hematol , vol.47 , pp. 115-123
    • Weiner, G.J.1
  • 29
    • 77951010885 scopus 로고    scopus 로고
    • Aggressive lymphomas
    • G Lenz, LM Staudt Aggressive lymphomas N Engl J Med 362 2010 1417 1429
    • (2010) N Engl J Med , vol.362 , pp. 1417-1429
    • Lenz, G.1    Staudt, L.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.